Regulation of metaplasia and dysplasia in the stomach by the stromal microenvironment

참고문헌 (98)

1. Giroux, V., "Metaplasia : tissue injury adaptation and a precursor to the dysplasia-cancer sequence", Nat. Rev. Cancer, 17, pp.594~604 (2017)
2. Goldenring, J. R., "Cellular plasticity, reprogramming, and regeneration : metaplasia in the stomach and beyond", Gastroenterology, 162, pp.415~430 (2022)
3. Schmidt, P. H., "Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma", Lab. Investig, 79, pp.639~646 (1999)
4. Fox, J. G., "Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL", 6 mice and p53 hemizygous transgenic mice, 1996, pp.110, 155~166
5. Lee, S. H., "Up-regulation of Aquaporin 5 defines spasmolytic polypeptide expressing metaplasia and progression to incomplete intestinal metaplasia", Cell Mol. Gastroenterol. Hepatol, 13, pp.199~217 (2022)
6. Shah, S. C., "Histologic subtyping of gastric intestinal metaplasia : overview and considerations for clinical practice", Gastroenterology, 158, pp.745~750 (2020)
7. Choi, E., "Expression of activated ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions", Gastroenterology, 150, pp.918~930 (2016)
8. Goldenring, J. R., "Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia : time for reevalua tion of metaplasias and the origins of gastric cancer", Gastroenterology, 138, pp.2207~2210 (2010)
9. Lauwers, G. Y., "Gastric epithelial dysplasia", Gut, 45, pp.784~790 (1999)
10. Riera, K. M., "Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa", J. Pathol, 251, pp.336~347 (2020)
11. Lee, S. H., "Apposition of fibroblasts with metaplastic gastric cells promotes dysplastic transition", Gastroenterology, 165, pp.374~390 (2023)
12. Blaser, M. J., "Parasitism by the “slow” bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia", J. Clin. Investig, 94, pp.4~8 (1994)
13. Yoshizawa, N., "Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori", Lab. Investig, 87, pp.1265~1276 (2007)
14. Nam, K. T., "Mature chief cells are cryptic progenitors for metaplasia in the stomach", Gastroenterology, 139, pp.2028~2037 (2010)
15. Goldenring, J. R., "Reversible drug-induced oxyntic atrophy in rats", Gastro enterology, 118, pp.1080~1093 (2000)
16. Manning, E. H., "Tamoxifen acts as a parietal cell protonophore", Cell Mol. Gastroenterol. Hepatol, 10, pp.655~657 (2020)
17. Nomura, S., "Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice", Am. J. Physiol. Gastrointest. Liver Physiol, 288, pp.G362~G375 (2005)
18. Huh, W. J., "Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach", Gastroenterology, 142, pp.21~24 (2012)
19. Caldwell, B., "Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa", Gut, 71, pp.1068~1077 (2022)
20. Min, J., "Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach", Nat. Commun, 10, pp.5549~ (2019)
21. Zhang, M., "Dissecting transcriptional heterogeneity in primary gastric ade nocarcinoma by single cell RNA sequencing", Gut, 70, pp.464~475 (2021)
22. Kim, J., "Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity", NPJ Precis. Oncol, 6, pp.9~ (2022)
23. Sathe, A., "Single-cell genomic characterization reveals the cellular repro gramming of the gastric tumor microenvironment", Clin. Cancer Res, 26, pp.2640~2653 (2020)
24. Fox, J. G., "Local and systemic immune responses in murine Helicobacter felis active chronic gastritis", Infect. Immun, 61, pp.2309~2315 (1993)
25. Osaki, L. H., "Interferon-gamma directly induces gastric epithelial cell death and is required for progression to metaplasia", J. Pathol, 247, pp.513~523 (2019)
26. El-Zaatari, M., "Aim2-mediated", IFN-beta-independent regulation of gastric metaplastic lesions via CD8+ T cells, 2020, pp.5, e94035~
27. Smythies, L. E., "Helicobacter pylori-induced mucosal inflammation is Th1mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice", J. Immunol, 165, pp.1022~1029 (2000)
28. Roth, K. A., "Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology", J. Immunol, 163, pp.1490~1497 (1999)
29. Ding, L., "Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia", J. Clin. Investig, 126, pp.2867~2880 (2016)
30. Petersen, C. P., "Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells", Gastro enterology, 146, pp.1727~1738 (2014)
31. Wynn, T. A., "Macrophage biology in development, homeostasis and disease", Nature, 496, pp.445~455 (2013)
32. Murray, P. J., "Protective and pathogenic functions of macrophage subsets", Nat. Rev. Immunol, 11, pp.723~737 (2011)
33. Busada, J. T., "Glucocorticoids and androgens protect from gastric metaplasia by suppressing Group 2 Innate lymphoid cell activation", Gastroenterology, 161, pp.637~652 (2021)
34. Meyer, A. R., "Group 2 innate lymphoid cells coordinate damage response in the stomach", Gastroenterology, 159, pp.2077~2091 (2020)
35. Petersen, C. P., "A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach", Gut, 67, pp.805~817 (2018)
36. Li, X., "Single-cell RNA sequencing reveals a pro-invasive cancer-associated f ibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer", Theranostics, 12, pp.620~638 (2022)
37. Chen, X., "Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis", J. Transl. Med, 20, pp.322~ (2022)
38. Zhang, J., "Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a", JAK2, Ann. Transl. Med, pp.2020, 8[DOI]
39. Biffi, G., "Diversity and biology of cancer-associated fibroblasts", Physiol. Rev, 101, pp.147~176 (2021)
40. Plikus, M. V., "Fibroblasts : origins, definitions, and functions in health and disease", Cell, 184, pp.3852~3872 (2021)
41. Bu, L., "Biological heterogeneity and versatility of cancer-associated fibro blasts in the tumor microenvironment", Oncogene, 38, pp.4887~4901 (2019)
42. Leedham, S. J., "The stomach periglandular fibroblast sheath : all present and correct", Gut, 55, pp.295~296 (2006)
43. Direkze, N. C., "Multiple organ engraftment by bone-marrow-derived myo f ibroblasts and fibroblasts in bone-marrow-transplanted mice", Stem Cells, 21, pp.514~520 (2003)
44. Weber, C. E., "Osteopontin mediates an MZF1-TGF-beta1-dependent trans formation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer", Oncogene, 34, pp.4821~4833 (2015)
45. Quante, M., "Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth", Cancer Cell, 19, pp.257~272 (2011)
46. LeBleu, V. S., "Origin and functional heterogeneity of fibroblasts", FASEB J, 34, pp.3519~3536 (2020)
47. Rhim, A. D., "Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma", Cancer Cell, 25, pp.735~747 (2014)
48. Ozdemir, B. C., "Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival", Cancer Cell, 25, pp.719~734 (2014)
49. Gabbiani, G., "Presence of modified fibroblasts in granu lation tissue and their possible role in wound contraction", Experientia, 27, pp.549~550 (1971)
50. Lendahl, U., "Identification, discrimination and hetero geneity of fibroblasts", Nat. Commun, 13, pp.3409~ (2022)
51. Ohlund, D., "Distinct populations of inflammatory fibroblasts and myofibro blasts in pancreatic cancer", J. Exp. Med, 214, pp.579~596 (2017)
52. Galie, M., "Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells", Carcinogenesis, 26, pp.1868~1878 (2005)
53. Kojima, Y., "Autocrine TGF-beta and stromal cell-derived factor-1(SDF-1)signaling drives the evolution of tumor-promoting mammary stromal myofi broblasts", Proc. Natl Acad. Sci. USA, 107, pp.20009~20014 (2010)
54. Guerrero-Juarez, C. F., "Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds", Nat. Com mun, 10, pp.650~ (2019)
55. Jotzu, C., "Adipose tissue-derived stem cells differentiate into carcinoma associated fibroblast-like cells under the influence of tumor-derived factors", Anal. Cell Pathol, 33, pp.61~79 (2010)
56. Mao, X., "Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment : new findings and future perspectives", Mol. Cancer, 20, pp.131~ (2021)
57. Biffi, G., "IL1-Induced JAK", STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma, 2019, pp.9, 282~301
58. Sahai, E., "A framework for advancing our understanding of cancer-associated f ibroblasts", Nat. Rev. Cancer, 20, pp.174~186 (2020)
59. Monteran, L., "The dark side of fibroblasts : cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment", Front. Immunol, 10, pp.1835~ (2019)
60. Helms, E. J., "Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer-associated fibroblasts", Cancer Discov, 12, pp.484~501 (2022)
61. Elyada, E., "Cross-species single-cell analysis of pancreatic ductal adeno carcinoma reveals antigen-presenting cancer-associated fibroblasts", Cancer Dis cov, 9, pp.1102~1123 (2019)
62. Utani, A., "Fibulin-2 binds to the short arms of laminin-5and laminin-1 via conserved amino acid sequences", J. Biol. Chem, 272, pp.2814~2820 (1997)
63. Costa, A., "Fibroblast heterogeneity and immunosuppressive environment in human breast cancer", Cancer Cell, 33, pp.463~479 (2018)
64. Pelon, F., "Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms", Nat. Commun, 11, pp.404~ (2020)
65. Sebastian, A., "Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer", Cancers, 12, pp.1307~ (2020)
66. Kumar, V., "Single-cell Atlas of Lineage States, tumor microenvironment, and subtype-specific expression programs in gastric cancer", Cancer Discov, 12, pp.670~691 (2022)
67. Nowicki-Osuch, K., "Single-cell RNA sequencing unifies developmental pro grams of esophageal and gastric intestinal metaplasia", Cancer Discov, 13, pp.1346~1363 (2023)
68. Zhang, Y., "Estrogen facilitates gastric cancer cell pro liferation and invasion through promoting the secretion of interleukin-6 by cancer-associated fibroblasts", Int. Immunopharmacol, 78, pp.105937~ (2020)
69. Zhu, L., "Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis", Oncogene, 35, pp.5388~5399 (2016)
70. Kasashima, H., "Lysyl oxidase-like 2(LOXL2)from stromal fibroblasts stimu lates the progression of gastric cancer", Cancer Lett, 354, pp.438~446 (2014)
71. Wu, X., "Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer", Cancer Lett, 335, pp.128~135 (2013)
72. Zhou, Q., "The reciprocal interaction between tumor cells and activated f ibroblasts mediated by TNF-alpha", IL-33, Oncogene, pp.2020, 39[DOI]
73. Comito, G., "Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression", Oncogene, 33, pp.2423~2431 (2014)
74. Kim, J. H., "The role of myofibroblasts in upregulation of S100A8 and S100A9and the differentiation of myeloid cells in the colorectal cancer microenviron ment", Biochem. Biophys. Res. Commun, 423, pp.60~66 (2012)
75. Zhang, A., "Cancer-associated fibroblasts promote M2 polarization of mac rophages in pancreatic ductal adenocarcinoma", Cancer Med, 6, pp.463~470 (2017)
76. Izumi, D., "CXCL12", CXCR4 activation by cancer-associated fibroblasts pro motes integrin beta1 clustering and invasiveness in gastric cancer, 2016, pp.138, 1207~1219
77. Pinchuk, I. V., "PD-1 ligand expression by human colonic myofibroblasts", f ibroblasts regulates CD4+ T-cell activity, 2008, pp.135, 1228~1237
78. Feig, C., "Targeting CXCL12 from FAP-expressing carcinoma-associated f ibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer", Proc. Natl Acad. Sci. USA, 110, pp.20212~20217 (2013)
79. Nazareth, M. R., "Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells", J. Immunol, 178, pp.5552~5562 (2007)
80. Richards, K. E., "Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells", Oncogene, 36, pp.1770~1778 (2017)
81. Grunberg, N., "Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat Shock Factor 1-mediated secretion of extracellular vesicles", Cancer Res, 81, pp.1639~1653 (2021)
82. Uchihara, T., "Extracellular vesicles from cancer-associated fibroblasts con taining Annexin A6 induces FAK-YAP activation by stabilizing beta1 integrin, enhancing drug resistance", Cancer Res, 80, pp.3222~3235 (2020)
83. Pitarresi, J. R., "Stromal ETS2 regulates chemokine production and immune cell recruitment during Acinar-to-Ductal Metaplasia", Neoplasia, 18, pp.541~552 (2016)
84. Behrens, P., "The Ets-1 tran scription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer", J. Pathol, 194, pp.43~50 (2001)
85. Behrens, P., "Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and-9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers", Int. J. Cancer, 107, pp.183~188 (2003)
86. Roy, S. A. B., "Loss of mesenchymal bone morphogenetic protein signaling leads to development of reactive stroma and initiation of the gastric neoplastic cascade", Sci. Rep, 6, pp.32759~ (2016)
87. Shinohara, M., "Bone morphogenetic protein signaling regulates gastric epithelial cell development and proliferation in mice", Gastroenterology, 139, pp.2050~2060 (2010)
88. Takabayashi, H., "Anti-inflammatory activity of bone morphogenetic protein signaling pathways in stomachs of mice", Gastroenterology, 147, pp.396~406 (2014)
89. Kapalczynska, M., "BMP feed-forward loop promotes terminal differentiation in gastric glands and is interrupted by H", pylori-driven inflammation. Nat. Commun, 13, pp.1577~ (2022)
90. Hutton, C., "Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity", Cancer Cell, 39, pp.1227~1244 (2021)
91. Hwang, Y. J., "Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication-a prospective study for up to 10 years", Aliment Pharm. Ther, 47, pp.380~390 (2018)
92. Wang, J., "Gastric atrophy and intestinal metaplasia before and after Heli cobacter pylori eradication : a meta-analysis", Digestion, 83, pp.253~260 (2011)
93. Loeffler, M., "Targeting tumor associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake", J. Clin. Investig, 116, pp.1955~1962 (2006)
94. Lo, A., "Tumor-promoting desmoplasia is disrupted by depleting FAP expressing stromal cells", Cancer Res, 75, pp.2800~2810 (2015)
95. Dorst, D. N., "Fibroblast activation protein-targeted photodynamic therapy of cancer-associated fibroblasts in murine models for pancreatic ductal adeno carcinoma", Mol. Pharm, 20, pp.4319~4330 (2023)
96. Huang, T. X., "Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity", Gut, 71, pp.333~344 (2022)
97. Akiyama, T., "Stromal reprogramming through dual PDGFRalpha", beta blockade boosts the efficacy of Anti-PD-1 Immunotherapy in fibrotic tumors, 2023, pp.83, 753~770
98. Sherman, M. H., "Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy", Cell, 159, pp.80~93 (2014)

관련 논문AI추천